🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Individuals with suspected primary immunodeficiency will be studied and the...
Status
Recruiting
Location
Division of Immunology
Start Date
2016-02
Trial ID
NCT02735824
Treatments Being Tested
This phase II trial tests how well adding lisocabtagene maraleucel (liso-ce...
Status
Active Not Recruiting
Location
City of Hope Medical Center
Start Date
2023-06-02
Trial ID
NCT05672173
Glioblastoma multiforme (GBM) is the most common primary brain tumor, and i...
Status
Not Yet Recruiting
Location
CHU Amiens
Start Date
2025-12
Trial ID
NCT07211841
Treatments Being Tested
This phase I/II trial studies the safety, side effects, and best dose of de...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2025-09-23
Trial ID
NCT06928662
This phase II trial studies how to improve the usage of Lu 177 vipivotide t...
Status
Suspended
Location
Mayo Clinic in Rochester
Start Date
2024-05-03
Trial ID
NCT06200103
Triple-negative breast cancer (TNBC) is an aggressive form of breast cancer...
Status
Not Yet Recruiting
Location
London Health Sciences Center
Start Date
2026-02
Trial ID
NCT07292142
Treatments Being Tested
This phase II trial studies the effect of rogaratinib in treating patients ...
Status
Active Not Recruiting
Location
City of Hope Comprehensive Cancer Center
Start Date
2021-05-03
Trial ID
NCT04595747
Our knowledge on cardiovascular side effects of immune checkpoint inhibitor...
Status
Completed
Location
AP-HP - Hôpital européen Georges-Pompidou
Start Date
2020-11-06
Trial ID
NCT04586894
Treatments Being Tested
This phase II MATCH treatment trial tests how well palbociclib (PD-0332991)...
Status
Active Not Recruiting
Location
ECOG-ACRIN Cancer Research Group
Start Date
2017-03-22
Trial ID
NCT06390839
This phase IV trial is evaluating whether morning versus afternoon administ...
Status
Recruiting
Location
OHSU Knight Cancer Institute
Start Date
2026-06-08
Trial ID
NCT07405086
Treatments Being Tested